½ÃÀ庸°í¼­
»óǰÄÚµå
1424383

ÇÙÀÇÇÐ À̹Ì¡ Àåºñ ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°

Nuclear Imaging Equipment Market, By Product Type (Single Photon Emission Computed Tomography, Positron Emission Tomography, Hybrid PET-CT, Hybrid SPECT-CT, Hybrid PET-MRI, and Others), By Application, By End User, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ÇÙÀÇÇÐ À̹Ì¡ Àåºñ ½ÃÀå ±Ô¸ð´Â 2023³â 30¾ï 7,000¸¸ ´Þ·¯¿¡¼­ 2030³â¿¡´Â 42¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ Áß ¿¬°£ Æò±Õ ¼ºÀå·ü(CAGR)Àº 4.9%¸¦ ³ªÅ¸³À´Ï´Ù.

¸®Æ÷Æ® ¹üÀ§ ¸®Æ÷Æ® »ó¼¼
±âÁسâ 2022³â 2023/2024³â ½ÃÀå ±Ô¸ð 30¾ï 7,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2018-2021³â ¿¹Ãø ±â°£ 2023-2030³â
¿¹Ãø ±â°£ 2023³â/2024-2030³â/2031³â CAGR 4.90% 2030/2031³â °¡Ä¡ ¿¹Ãø 42¾ï 9,000¸¸ ´Þ·¯
µµÇ¥ 1. ¼¼°èÀÇ ÇÙÀÇÇÐ À̹Ì¡ Àåºñ ½ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2023³â
Nuclear Imaging Equipment Market-IMG1

ÇÙÀÇÇÐÀº ¼Ò·®ÀÇ ¹æ»ç¼º ¹°ÁúÀ» »ç¿ëÇÏ¿© ´Ù¾çÇÑ À¯ÇüÀÇ ¾Ï, ½ÉÀ庴 ¹× ±âŸ ½Åü ÀÌ»óÀ» Æ÷ÇÔÇÑ ´Ù¾çÇÑ Áúº´À» Áø´ÜÇϰųª Ä¡·áÇÏ´Â ÀÇ·á ¿µ»ó Áø´ÜÀÇ ÇÑ ºÐ¾ßÀÔ´Ï´Ù. ÇÙÀÇÇÐ ¿µ»óÁø´ÜÀº Àå±â, Á¶Á÷, »ÀÀÇ ±â´ÉÀ» ±â¹ÝÀ¸·Î ÀÇÇÐÀû ¹®Á¦ÀÇ ¿øÀÎÀ» ÆÄ¾ÇÇÕ´Ï´Ù. ÀÌ Á¡ÀÌ ¿¢½º·¹ÀÌ °Ë»ç³ª ÃÊÀ½ÆÄ °Ë»ç µî ±¸Á¶Àû ¿Ü°üÀ» ÅëÇØ Áúº´ÀÇ À¯¹«¸¦ ÆÇ´ÜÇÏ´Â Áø´Ü °Ë»ç¿Í´Â ´Ù¸¥ Á¡ÀÔ´Ï´Ù. ÇÙÀÇÇÐ ¶Ç´Â ¹æ»ç¼º ÇÙÁ¾ ¿µ»ó °Ë»ç´Â ºñħ½ÀÀûÀ̰í ÀϹÝÀûÀ¸·Î ÅëÁõÀÌ ¾ø´Â ÀÇ·á °Ë»ç·Î Àǻ簡 Áúº´À» Áø´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ¿µ»ó °Ë»ç¿¡´Â ¹æ»ç¼º ÀǾàǰ ¶Ç´Â ¹æ»ç¼º ÃßÀûÀÚ¶ó°í ºÒ¸®´Â ¹æ»ç¼º ¹°ÁúÀÌ »ç¿ëµË´Ï´Ù. ÇÙÀÇÇÐ °Ë»çÀÇ À¯Çü¿¡ µû¶ó ¹æ»ç¼º ÃßÀûÀÚ´Â Á¤¸Æ¿¡ ÁÖ»çÇϰųª »ïŰ°Å³ª ±âü·Î ÈíÀÔÇÏ¿© °Ë»ç ´ë»ó ±â°üÀ̳ª ºÎÀ§¿¡ ÃàÀûµÇ¾î °¨¸¶¼± ÇüÅ·Π¿¡³ÊÁö¸¦ ¹æÃâÇÕ´Ï´Ù. ÀÌ ¿¡³ÊÁö´Â °¨¸¶ Ä«¸Þ¶ó, (¾çÀüÀÚ ´ÜÃþ ÃÔ¿µ) PET ½ºÄ³³Ê, ÇÁ·Îºê¶ó´Â Àåºñ·Î °¨ÁöµË´Ï´Ù.

½ÃÀå ¿ªÇÐ :

´Ù¾çÇÑ ¾ÏÀÇ ¼¼°è À¯º´·ü Áõ°¡´Â ¿¹Ãø ±â°£ Áß ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ ¿¬±¸°³¹ß(R&D) Áõ°¡¿Í ½ÃÀå ÁøÃâ±â¾÷ÀÇ Á¦Ç° Ãâ½Ã Áõ°¡´Â ¿¹Ãø ±â°£ Áß ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀÔ´Ï´Ù. ¿¹¸¦ µé¾î ¹Ì±¹ ¾Ï Çùȸ°¡ 2021³â 2¿ù 4ÀÏ ¹ßÇ¥ÇÑ ÀÚ·á¿¡ µû¸£¸é 2020³â Àü ¼¼°è¿¡¼­ ¾à 1,930¸¸ ¸íÀÇ ½Å±Ô ¾Ï ȯÀÚ¿Í 1,000¸¸ ¸íÀÇ ¾Ï »ç¸ÁÀÚ°¡ ¹ß»ýÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • ¸®Æ÷Æ® ¼³¸í
    • ½ÃÀåÀÇ Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • ÃËÁø¿äÀÎ
  • ¾Ï°ú ½ÉÀ庴ÀÇ ¹ß»ý·ü Áõ°¡
  • ¿µ»ó Áø´Ü ¸ð´Þ¸®Æ¼¿¡¼­ ±â¼úÀÇ Áøº¸
    • ¾ïÁ¦¿äÀÎ
  • ÇÙ¿µ»ó Áø´Ü ¸ð´Þ¸®Æ¼ÀÇ °íºñ¿ë
    • ±âȸ
  • ÇÏÀ̺긮µå ¿µ»ó ¸ð´Þ¸®Æ¼
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Á¦Ç° ¹ß¸Å/½ÂÀÎ
  • PEST ºÐ¼®
  • PorterÀÇ »ê¾÷ ºÐ¼®
  • ÇÕº´, Àμö, Çù¾÷

Á¦4Àå ¼¼°èÀÇ ÇÙÀÇÇÐ À̹Ì¡ Àåºñ ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

  • ½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19)ÀÇ ¿ªÇÐ
  • °ø±ÞÃø°ú ¼ö¿äÃø ºÐ¼®
  • °æÁ¦Àû ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ÇÙÀÇÇÐ À̹Ì¡ Àåºñ ½ÃÀå, Á¦Ç° À¯Çüº°, 2018-2030³â

  • ¼­·Ð
  • ´ÜÀÏ ±¤ÀÚ ¹æ»ç ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µ¹ý(SPECT)
  • ¾çÀüÀÚ¹æÃâ´ÜÃþÃÔ¿µ¹ý(PET)
  • ÇÏÀ̺긮µå PET-CT
  • ÇÏÀ̺긮µå SPECT-CT
  • ÇÏÀ̺긮µå PET-MRI
  • ±âŸ

Á¦6Àå ¼¼°èÀÇ ÇÙÀÇÇÐ À̹Ì¡ Àåºñ ½ÃÀå, ¿ëµµº°, 2018-2030³â

  • ¼­·Ð
  • Á¾¾çÇÐ
  • ½ÉÀ庴ÇÐ
  • ½Å°æ ³»°ú
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ ÇÙÀÇÇÐ À̹Ì¡ Àåºñ ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2018-2030³â

  • ¼­·Ð
  • º´¿ø°ú Ŭ¸®´Ð
  • ¿µ»ó Áø´Ü ¼¾ÅÍ
  • ¿¬±¸±â°ü
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ ÇÙÀÇÇÐ À̹Ì¡ Àåºñ ½ÃÀå, Áö¿ªº°, 2018-2030³â

  • ¼­·Ð
  • ºÏ¹Ì
  • ¹Ì±¹
  • ij³ª´Ù
  • À¯·´
  • ¿µ±¹
  • µ¶ÀÏ
  • ÇÁ¶û½º
  • ÀÌÅ»¸®¾Æ
  • ½ºÆäÀÎ
  • ·¯½Ã¾Æ
  • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áß±¹
  • ÀϺ»
  • Àεµ
  • È£ÁÖ
  • ASEAN ±¹°¡
  • Çѱ¹
  • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • ºê¶óÁú
  • ¸ß½ÃÄÚ
  • ¾Æ¸£ÇîÆ¼³ª
  • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿
  • GCC ±¹°¡
  • À̽º¶ó¿¤
  • ±âŸ Áßµ¿
  • ¾ÆÇÁ¸®Ä«
  • ³²¾ÆÇÁ¸®Ä«
  • ºÏ¾ÆÇÁ¸®Ä«
  • Áß¾Ó¾ÆÇÁ¸®Ä«

Á¦9Àå °æÀï ±¸µµ

  • ±â¾÷ °³¿ä
    • GE Healthcare
    • Siemens Healthineers
    • Philips Healthcare
    • Canon Medical Systems
    • Mediso Medical Imaging Systems
    • MIE America
    • DDD Diagnostic
    • Segami
    • Digirad

Á¦10Àå ¼½¼Ç

  • Âü°í ¹®Çå
  • Á¶»ç ¹æ¹ý
  • ÃâÆÇ»ç ¼Ò°³
KSA 24.02.23

Global nuclear imaging equipment market size is expected to reach US$ 4.29 Bn by 2030, from US$ 3.07 Bn in 2023, exhibiting a compound annual growth rate (CAGR) of 4.9% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023/2024: US$ 3.07 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023/2024 to 2030/2031 CAGR: 4.90% 2030/2031 Value Projection: US$ 4.29 Bn
Figure 1. Global Nuclear Imaging Equipment Market Share (%), By Region, 2023
Nuclear Imaging Equipment Market - IMG1

Nuclear medicine is a branch of medical imaging that uses small amounts of radioactive material to diagnose or treat a variety of diseases, including many types of cancers, heart disease and certain other abnormalities within the body. Nuclear imaging determines the cause of the medical problem based on the function of the organ, tissue or bone. This is how nuclear imaging differs from an X-ray, ultrasound or any other diagnostic test that determines the presence of disease based on structural appearance. Nuclear medicine or radionuclide imaging procedures are noninvasive and usually painless medical tests that help physicians diagnose medical conditions. These imaging scans use radioactive materials called radiopharmaceuticals or radiotracers. Depending on the type of nuclear medicine exam are done, the radiotracer is either injected into a vein, swallowed or inhaled as a gas and eventually accumulates in the organ or area of your body being examined, where it gives off energy in the form of gamma rays. This energy is detected by a device called a gamma camera, a (positron emission tomography) PET scanner and/or probe.

Market Dynamics:

Increasing prevalence of various cancers globally is expected to propel the market growth over the forecast period. Moreover, increasing research and development (R&D) and increasing product launches by the market players will aid in the market growth over the forecast period. For instance, according to the data published by the American Cancer Society on February 4, 2021, worldwide, an estimated 19.3 Mn new cancer cases and 10 Mn cancer deaths occurred in 2020.

Detailed Segmentation:

  • Global Nuclear Imaging Equipment Market, By Product Type
    • Single Photon Emission Computed Tomography (SPECT)
    • Positron Emission Tomography (PET)
    • Hybrid PET-CT
    • Hybrid SPECT-CT
    • Hybrid PET-MRI
    • Others
  • Global Nuclear Imaging Equipment Market, By Application
    • Oncology
    • Cardiology
    • Neurology
    • Others
  • Global Nuclear Imaging Equipment Market, By End User
    • Hospitals and clinics
    • Diagnostic imaging centers
    • Research institutes
    • Others
  • Global Nuclear Imaging Equipment Market, By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
  • Top Companies in Global Nuclear Imaging Equipment Market:
    • GE Healthcare
    • Siemens Healthineers
    • Philips Healthcare
    • Canon Medical Systems
    • Mediso Medical Imaging Systems
    • MIE America
    • DDD Diagnostic
    • Segami
    • Digirad

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing incidence of cancer & cardiac disease
  • Technological advancements in imaging modalities
    • Restraints
  • High cost of nuclear imaging modalities
    • Opportunities
  • Hybrid imaging modalities
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Mergers, Acquisitions, and Collaborations

4. Global Nuclear Imaging Equipment Market- Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Nuclear Imaging Equipment Market, By Product Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Single Photon Emission Computed Tomography (SPECT)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Positron Emission Tomography (PET)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Hybrid PET-CT
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Hybrid SPECT-CT
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Hybrid PET-MRI
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Global Nuclear Imaging Equipment Market, By Application, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Cardiology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Neurology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Global Nuclear Imaging Equipment Market, By End User, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023and 2030 (%)
    • Y-o-Y Growth Analysis, 2019- 2030
    • Segment Trends
  • Hospitals and clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Diagnostic imaging centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Research institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

8. Global Nuclear Imaging Equipment Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2023and 2030 (%)
    • Y-o-Y Growth Analysis, For Region, 2019-2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • China
  • Japan
  • India
  • Australia
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Bn)
  • South Africa
  • North Africa
  • Central Africa

9. Competitive Landscape

  • Company Profile
    • GE Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
    • Siemens Healthineers
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Philips Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Canon Medical Systems
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Mediso Medical Imaging Systems
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • MIE America
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • DDD Diagnostic
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Segami
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Digirad
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Analyst Views

10. Section

  • References
  • Research Methodology
  • About us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦